Study details
Enrolling now
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT
M.D. Anderson Cancer Center
NCT IDNCT05054296ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
200
Study length
about 6.9 years
Ages
18+
Sex
Male only
Locations
1 site in TX
What this study is about
This trial is testing if an exercise program with continuous Fitbit monitoring can help manage metabolic syndrome and cardiovascular disease risk in prostate cancer patients receiving androgen deprivation therapy. The goal is to see if this approach improves their overall health and well-being.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Educational Intervention
- 2.Participate in Exercise Intervention
- 3.Quality-of-Life Assessment
- +2 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
therapy
Devices
wearable
Body systems
Oncology